Literature DB >> 23855806

Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions.

Gauthier J-P Deblonde1, Manuel Sturzbecher-Hoehne, Rebecca J Abergel.   

Abstract

The solution thermodynamics of water-soluble complexes formed between Ce(III), Ce(IV), Th(IV) and the octadentate chelating agent 3,4,3-LI(1,2-HOPO) were investigated. Several techniques including spectrofluorimetric and automated spectrophotometric titrations were used to overcome the slow spontaneous oxidation of Ce(III) complexes yielding to stability constants of log β110 = 17.4 ± 0.5, log β11-1 = 8.3 ± 0.4 and log β111 = 21.2 ± 0.4 for [Ce(III)(3,4,3-LI(1,2-HOPO))](-), [Ce(III)(3,4,3-LI(1,2-HOPO)(OH)](2-), and [Ce(III)(3,4,3-LI(1,2-HOPO)H], respectively. Using the spectral properties of the hydroxypyridinonate chelator in ligand competition titrations against nitrilotriacetic acid, the stability constant log β110 = 41.5 ± 0.5 was determined for [Ce(IV)(3,4,3-LI(1,2-HOPO))]. Finally, the extraordinarily stable complex [Ce(IV)(3,4,3-LI(1,2-HOPO))] was used in Th(IV) competition titrations, resulting in a stability constant of log β110 = 40.1 ± 0.5 for [Th(IV)3,4,3-LI(1,2-HOPO))]. These experimental values are in excellent agreement with previous estimates, they are discussed with respect to the ionic radius and oxidation state of each cationic metal, and allow predictions on the stability of other actinide complexes including [U(IV)(3,4,3-LI(1,2-HOPO))], [Np(IV)(3,4,3-LI(1,2-HOPO))], and [Pu(IV)(3,4,3-LI(1,2-HOPO))]. Comparisons with the standard ligand diethylenetriamine pentaacetic acid (DTPA) provide a thermodynamic basis for the observed significantly higher efficacy of 3,4,3-LI(1,2-HOPO) as an in vivo actinide decorporation agent.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23855806      PMCID: PMC3771511          DOI: 10.1021/ic4010246

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  10 in total

1.  Aqueous complexation of thorium(IV), uranium(IV), neptunium(IV), plutonium(III/IV), and cerium(III/IV) with DTPA.

Authors:  M Alex Brown; Alena Paulenova; Artem V Gelis
Journal:  Inorg Chem       Date:  2012-06-27       Impact factor: 5.165

2.  Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands.

Authors:  D L White; P W Durbin; N Jeung; K N Raymond
Journal:  J Med Chem       Date:  1988-01       Impact factor: 7.446

3.  Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs.

Authors:  P Gans; A Sabatini; A Vacca
Journal:  Talanta       Date:  1996-10       Impact factor: 6.057

4.  GLEE, a new computer program for glass electrode calibration.

Authors:  P Gans; B O'Sullivan
Journal:  Talanta       Date:  2000-01-24       Impact factor: 6.057

5.  3,4,3-LI(1,2-HOPO): in vitro formation of highly stable lanthanide complexes translates into efficacious in vivo europium decorporation.

Authors:  Manuel Sturzbecher-Hoehne; Clara Ng Pak Leung; Anthony D'Aléo; Birgitta Kullgren; Anne-Laure Prigent; David K Shuh; Kenneth N Raymond; Rebecca J Abergel
Journal:  Dalton Trans       Date:  2011-07-15       Impact factor: 4.390

6.  Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).

Authors:  Rebecca J Abergel; Patricia W Durbin; Birgitta Kullgren; Shirley N Ebbe; Jide Xu; Polly Y Chang; Deborah I Bunin; Eleanor A Blakely; Kathleen A Bjornstad; Chris J Rosen; David K Shuh; Kenneth N Raymond
Journal:  Health Phys       Date:  2010-09       Impact factor: 1.316

7.  Using the antenna effect as a spectroscopic tool: photophysics and solution thermodynamics of the model luminescent hydroxypyridonate complex [Eu(III)(3,4,3-LI(1,2-HOPO))]-.

Authors:  Rebecca J Abergel; Anthony D'Aléo; Clara Ng Pak Leung; David K Shuh; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2009-12-07       Impact factor: 5.165

8.  Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.

Authors:  Patricia W Durbin
Journal:  Health Phys       Date:  2008-11       Impact factor: 1.316

9.  Characterisation of thorium-ethylenediaminetetraacetic acid and thorium-nitrilotriacetic acid species by electrospray ionisation-mass spectrometry.

Authors:  Andrew J Cartwright; Colin C May; Paul J Worsfold; Miranda J Keith-Roach
Journal:  Anal Chim Acta       Date:  2007-03-12       Impact factor: 6.558

10.  Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.

Authors:  J Xu; B Kullgren; P W Durbin; K N Raymond
Journal:  J Med Chem       Date:  1995-07-07       Impact factor: 7.446

  10 in total
  11 in total

1.  Chelation and stabilization of berkelium in oxidation state +IV.

Authors:  Gauthier J-P Deblonde; Manuel Sturzbecher-Hoehne; Peter B Rupert; Dahlia D An; Marie-Claire Illy; Corie Y Ralston; Jiri Brabec; Wibe A de Jong; Roland K Strong; Rebecca J Abergel
Journal:  Nat Chem       Date:  2017-04-10       Impact factor: 24.427

2.  Characterization, HPLC method development and impurity identification for 3,4,3-LI(1,2-HOPO), a potent actinide chelator for radionuclide decorporation.

Authors:  Mingtao Liu; Jennie Wang; Xiaogang Wu; Euphemia Wang; Rebecca J Abergel; David K Shuh; Kenneth N Raymond; Paul Liu
Journal:  J Pharm Biomed Anal       Date:  2014-10-22       Impact factor: 3.935

Review 3.  Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".

Authors:  Romain Eychenne; Michel Chérel; Férid Haddad; François Guérard; Jean-François Gestin
Journal:  Pharmaceutics       Date:  2021-06-18       Impact factor: 6.321

4.  New insights into structure and luminescence of Eu(III) and Sm(III) complexes of the 3,4,3-LI(1,2-HOPO) ligand.

Authors:  Lena J Daumann; David S Tatum; Benjamin E R Snyder; Chengbao Ni; Ga-lai Law; Edward I Solomon; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2015-02-19       Impact factor: 15.419

5.  Ultra-selective ligand-driven separation of strategic actinides.

Authors:  Gauthier J-P Deblonde; Abel Ricano; Rebecca J Abergel
Journal:  Nat Commun       Date:  2019-06-04       Impact factor: 14.919

6.  Combinatorial design of multimeric chelating peptoids for selective metal coordination.

Authors:  Abel Ricano; Ilya Captain; Korey P Carter; Bryan P Nell; Gauthier J-P Deblonde; Rebecca J Abergel
Journal:  Chem Sci       Date:  2019-06-12       Impact factor: 9.825

Review 7.  Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.

Authors:  Xu Zhou; Linlin Dong; Langtao Shen
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

8.  Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).

Authors:  Melissa A Deri; Shashikanth Ponnala; Brian M Zeglis; Gabor Pohl; J J Dannenberg; Jason S Lewis; Lynn C Francesconi
Journal:  J Med Chem       Date:  2014-05-19       Impact factor: 7.446

9.  Hydroxypyridinone Derivatives: A Low-pH Alternative to Polyaminocarboxylates for TALSPEAK-like Separation of Trivalent Actinides from Lanthanides.

Authors:  Yufei Wang; Gauthier J-P Deblonde; Rebecca J Abergel
Journal:  ACS Omega       Date:  2020-05-28

Review 10.  Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms.

Authors:  M Amélia Santos; Anna Irto; Péter Buglyó; Sílvia Chaves
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.